RESUMO I Uma enfermeira religiosa (Clínica Mayo) descobriu a relação entre metástases umbilicais (nódulo da Irmã Maria José) e neoplasias malignas avançadas intra-abdominais, inoperáveis (ovário, cólon, estômago, pâncreas, útero). Os autores apresentam um doente com cancro do cólon disseminado e metástase umbilical, interpretada inicialmente como hérnia umbilical. Revêem-se: características anatómicas do umbigo, e sua relação com ligamentos do umbigo contendo estruturas embriológicas residuais; a sua rede vascular arterial, venosa e linfática, todos estes elementos importantes para a compreensão da forma de ocorrência de metástases umbilicais; neoplasias primitivas. Consideram-se aspectos do diagnóstico clínico, radiológico, citoló-gico e histopatológico. Embora haja referências raras de melhor sobrevivência em alguns tumores, com terapêutica cirúrgica agressiva e quimioterapia adjuvante, o tratamento destes doentes é habitualmente tão só paliativo. GE -J Port Gastrenterol 2010;17:266-270 PALAVRAS CHAVE: Nódulo da Irmã Maria José, cancro do cólon, metástases umbilicais.
INTRODUCTION
Cutaneous metastases of malignant neoplasm are not common, occurring between 0.7 and 9 percent of autopsies 1 . Malignant metastases to the umbilicus, also known as Sister Mary Joseph's nodule or node, and also called Sister Mary Joseph sign, are rare and represent only 10 percent of all secondary tumors to the skin. The first medical report of metastasis to the umbilicus due to visceral carcinomas was done by Walshe et al.
in 1846. According to the Tanchov's review of Walshe's data, the author found only two cases of secondary umbilical involvement among 9118 cancer deaths that occurred in the period of 1830-1840 2 . In 1864 Storer et al reported a complete case study of a metastatic umbilical nodule due to gastric adenocarcinoma. However, the association of umbilical tumor nodules and visceral carcinomas was firmly established only after the clinical observations of a religious nurse from the future Mayo Clinic. Cutaneous metastasis are generally a sign of advanced malignant disease and portend a poor prognosis [3] [4] . In several series there was an average survival of 10 months after the appearance of such lesion. It is usual to consider that the finding of a metastatic nodule at the umbilical site almost certainly establishes the inoperability of the patient. However, although uncommonly, the presence of a malignant umbilical tumor is not sufficient proof of the existence of widespread metastatic disease.
According to a review of the literature pre-dating modern radiological and pathologic methods, umbilical nodules could be due to a primary umbilical tumor in 38% of cases, endometriosis in 32% of individuals, and the remaining 30% are actually secondary deposits of tumors found in the gastrointestinal tract in 35% to 65% of patients (most often pancreatic tail and body, gastric or colon cancer), or in the genitourinary tract in 12% to 35% of cases (mostly ovarian but also uterine cancer). It is estimated that 1% to 3% of the abdominal-pelvic malignancies metastasize to the umbilicus. In addition, about 3 -6% of cases are due to hematological malignancies, lung or breast cancers. Other uncommon primary tumors reported include gallbladder, liver, small bowel, appendix, fallopian tube, penis, kidney, and prostate. Very rare causes of umbilical metastases are abdominal desmoplastic round cell tumor, malignant peritoneal mesothelioma, and melanoma 3, 5 . Before the study possibilities of the modern radiologic techniques, the primary origin of the tumor was unknown in 15% to 30% of the cases 1 . It is important to have the clinical notion that an apparently insignificant umbilical nodule, may be the only manifestation of an underlying advanced malignant disease and therefore clinicians should be aware of such nodule 6 . Sister Mary Joseph's nodule usually present as a painful lump on the anterior abdominal wall, with different morphologic character: a) inflammatory erythematous thickening of the overlying skin resembling cellulitis; b) vascular appearance; c) fissures or ulceration; d) imitating incarcerated umbilical hernia 7 . It has irregular margins and a hard fibrous consistency. The surface may be ulcerated and necrotic, and may have a bloody, or a serous, or a purulent, or mucoid discharge coming out of it. The colour range is also wide and has been described as white, bluishviolet, or brownish-red. It is occasionally pruritic. The size of the nodule usually ranges from 0.5 to 2 cm, although some protruding nodules may reach up to 10 cm in size [8] [9] . Dr. Mayo relied a great deal on her assistance and wisdom. Once, when asked a technical question regarding what he would do in a certain clinical circumstance, he replied, "I would consult Sister Joseph and follow her advice". She could anticipate every act of Dr. Mayo during surgery and because she had very small hands, she could reach areas inaccessible to Dr. Mayo. She often incised the integument herself, before Dr. Mayo started the operation. Moreover, she also ended the operation by closing the wound. She was able to predict malignant findings at laparotomy if she felt an umbilical mass while scrubbing the abdomen during aseptic preparation for surgery 11 . Dr. Mayo first reported the condition as "pants-button umbilicus" (without credit to Sister Mary Joseph) in a lecture to the Cincinnati Academy of Medicine in 1928. The eponymous term "Sister Mary Joseph's nodule" was proposed by Sir Hamilton Bailey in 1949 to accredit Dr. Mayo's brilliant assistant 12 . Because Sister Mary Joseph later removed Mary of her name, the sign has also been referred to as Sister Joseph's nodule. Sister Mary worked until her death at the age of 82 of bronchopneumonia. Before she died according to some reports, she noticed the presence of the nodule within her umbilicus.
CLINICAL REPORT
A 56-year-old white male, a retired soccer player and trainer, who had a pacemaker implanted 10 years ago due to complete atrium-ventricular block, was admitted in our Unit in October 2008 for workup of a suspected malignancy. The patient claimed that for the past two years his stools were alternately solid and diarrheic, and had intermittent hematochezia. There was no medical consultation done during that time. During the previous year he noticed a slowing progressive enlargement of the umbilical area, sometimes with inflamed appearance and rarely with oozing, that was considered to be due to herniation. Three months prior to admission, the patient experienced anorexia and 10% weight loss. A month prior to admission he was having low back pains and just before admission the patient complained of early satiety and a mild left testicular pain. He denied fever or constipation.
On physical examination, the patient appeared in good nutritional state. There was no pallor, jaundice, cyanosis or peripheral edema. No lymphadenopathy was detected. The exam of the neck was normal, and the lung and heart exam also did not reveal abnormalities. In the abdomen there was an oozing ulcerated nodular lesion measuring 6.5 cm x 5.5 cm (suspected to be a Sister Mary Joseph's nodule) observed at the umbilical region (Fig. 1) . The nodule has an irregular surface, was hard and slightly tender on palpation, and there was no hepatomegaly and no splenomegaly on abdominal palpation. Rectal exam revealed a soft, enlarged prostate.
A day before admission the patient underwent a CT scan of the thorax, abdomen and pelvis which demonstrated generalized lymphadenopathy with involvement of the supra-clavicular, axillary, mediastinial, lumbar-aortic, celiac, mesenteric, inguinal and retrocrural territories; secondary micronodular pulmonary deposits; infiltration of the great omentum, moderately voluminous non-pure ascites; nodular lesion of the left adrenal; slightly diffusely heterogenic liver. The CT scan findings on the liver did not favor liver neoplasm infiltration. The umbilical area was interpreted as an empty umbilical hernia, but on review we diagnosed a nodular umbilical tumor (Fig. 2) .
Relevant laboratory tests at admission showed: normal CBC, normal levels of serum albumin, PSA, glucose, BUN and creatinine, normal thyroid function tests, normal serum protein electrophoresis; slightly low serum transferrin level; slightly elevated serum levels of γ-GT and of LDH; elevated levels of CEA: 137.7 ng/ml (N < 5.0), CA 19.9 219.3 U/ml (N < 37.0), hCG 30.6 mUI/ml (N < 2.7), and very high levels of α-fetoprotein 10.878 ng/ml (N < 10.0) . A testicular ultrasound showed no mass, only a small bilateral hydrocele and a small left varicocele. A CT scan of the lumbar spine did not reveal any spinal metastasis. Cytology of a left supra-clavicular lymphadenopathy ( Fig 3A) and of the umbilical nodule (Fig. 3B) showed secondary deposits of an adenocarcinoma. Colonoscopy was done and revealed (at 30 cm level) the presence of: 1) an ulcerated exophytic mass 40 mm wide (Fig. 4) , which histology demonstrated a moderately differentiated adenocarcinoma (Fig. 5) . 2) Two polyps that were removed by polypectomy revealing a tubulovillous adenoma and a tubular adenoma, both with low-grade dysplasia on histopathologic exam. The patient was transferred to the Medical Oncology Unit of the Portuguese Institute of Oncology in Lisbon (IPOL).
A diagnosis of stage IV colon cancer was made. Since the patient was symptomatic, he was started on chemotherapy. The pacemaker posed a relative contraindication to the placement of a central venous line for 5-fluoruracil infusion, so he was instead given a combination treatment of capecitabine and oxiplatin. He was submitted to four cycles of therapy. For the increasing lumbar pain, a bone scan was performed which showed heterogenous fixation on the lumbar vertebrae. A repeat CT scan of the lumbar spine was also done, revealing a pathological fracture of the 2nd lumbar (L2) vertebral body. There was an osteolytic lesion with a soft tissue component that merged with the large retroperitoneal lymphadenopathies. Palliative radiotherapy was given (30 Gy in 10 fractions), including L2 and nearby lymphadenopathies.
In March 2009 the patient was brought to the emergency room of the IPOL with pain, nausea and vomiting. Chemotherapy was stopped, considering the side effects and the disease progression, supportive treatment was given and analgesic medication was switched to transdermal opioids. Two weeks later he was admitted on IPOL with delirium, dehydration and pneumonia. He died the next day.
DISCUSSION
To better understand the occurrence of umbilicus metastasis it is important to remember certain aspects of the umbilical anatomy 13 : a) the sheath of both rectus abdominis muscles which is formed by the fusion of the aponeuroses of the external oblique, internal oblique and transversus abdominis muscle; b) the linea alba formed by the midline fusion of the sheaths of both rectus muscles, extending from the xiphoid process to the symphysis pubis; c) the umbilicus consists of a puckered scar through the linea alba at the former attachment of the umbilical cord. The umbilical ring is a scar invaginated on the abdominal wall between the transversalis fascia and peritoneum ring; d) the fascia transversalis lying deep to the linea alba and just superficial to the peritoneum. The umbilical ring is in fact a scar invaginated on the abdominal wall between the fascia transversalis and peritoneum; e) the fascia umbilicalis is a thickening of the fascia transversalis, which support the floor of the umbilicus.
There are several ligaments, or peritoneal folds, consistently found in adults that connect with the umbilicus and that contain remnants of the obliterated fetal structures such as: a) the median umbilical ligament, or urachus, is the obliterated allantois, which formerly connected the umbilicus to the bladder; b) the medial umbilical ligaments represent the obliterated umbilical arteries; c) the ligamentum teres, the most inferior part of the falciform ligament, contains the obliterated umbilical vein; d) an additional ligament connecting the umbilicus to the ileum is sometimes present and represents an obliterated remnant of the vitelline duct, which connect the yolk sac to the midgut 13 . The vascular supply to the anterior abdominal wall including the periumbilical region includes: a) the main arteriesthe inferior epigastric and deep circumflex iliac (branches of the external iliac artery) and the superior epigastric (a branch of the internal thoracic artery); b) venous drainage -into a network of veins radiating from the umbilicus to the axillary vein above via the lateral thoracic vein and the femoral vein below via the superficial epigastric vein. Small paraumbilical veins connect with the portal system along the ligamentum teres; c) the superficial lymphatic drainage of the periumbilical region connects with the axillary nodes above and the inguinal nodes below. Deep lymphatic drainage is via the internal thoracic, external iliac and abdominal paraaortic nodes and with the caval vein system; 3) lymphatic spread via the four sets of lymphatic pass from the umbilical region where there are connections with axillary, inguinal and periaortic lymph nodes; 4) direct extension along the ligaments of embryonic origin (round ligament of the liver, the urachus, the vittelointestinal duct remnant, and the obliterated vitelline artery), that connect with the umbilicus and contain remnants of the obliterated fetal structures 7, 13 . All the connections with multiple embryonic remnants and the extensive vascular and lymphatic communications, and the proximity of the umbilical scar to the anterior peritoneal surface, help to understand the source of metastasis to the umbilicus mostly from the abdomen and pelvis, but also from the thorax 14 . Therefore, theoretically, all types of cancer may disseminate to the umbilical region, but the most prevalent primary sites are from intra-abdominal origin.
Patients with Sister Mary Joseph's nodule may complain of a number of clinical symptoms consistent with intra-abdominal cancer, including epigastric pain, abdominal distention, weight loss, nausea and ascites. The signs of umbilical nodules metastasis are generally evident on physical examination, but they are sometimes overlooked in obese patients. A radiologist can be the first to diagnose an umbilical nodule, owing to the large number of cross-sectional imaging studies performed in patients suspected to suffer from malignancy. Whatever the source of umbilical metastasis, the Sister Mary Joseph's nodule may occur as a dermal, subcutaneous or peritoneal deposit, and this can be easily demonstrated in ultrasound and in contrasted computerized tomography 13 . Differential diagnosis of umbilical metastasis of tumors should include umbilical hernia, cutaneous endometriosis, benign tumors such as foreign body granuloma, melanocytic nevi, papilloma, cutaneous epithelial inclusion cysts, keloid, myxoma, and primary umbilical malignancy, including melanoma, squamous and basal cell carcinoma, and sarcoma.
After excluding umbilical hernia, the diagnosis of umbilical nodules should be obtained by fine needle aspiration for cytological examination which is easy to perform, if necessary with ultrasound guidance 15 . A skin biopsy for histopathological examination can best define the type of the tumor. The hematoxylin-eosin stain may differentiate primary and metastatic tumors. Moreover, immunohistochemical analysis may define the cellular origin in 72% of cases of unknown primary tumor. The use of electron microscopy and cytogenetic analysis may enhance the diagnostic sensitivity and specificity of the diagnosis. These methods enable the clinician to obtain a correct diagnosis of the situation without exposing the patient to time-consuming, invasive, expensive and useless diagnostic procedures. With this information the physician can best decide what will be the best way to search for the primary tumor.
As Sister Mary Joseph's nodule usually means the presence of widespread metastasis, the treatment of these patients commonly is only palliative. However, some authors postulate that depending somewhat of the type of tumor and of it primary origin, some patients can have better survival when treated aggressively with both surgery and adjunctive therapy 1 . Nevertheless the appropriateness of such therapy is determined by the clinical state of the patient. Despite the advanced stage of the disease in our patient, his good performance index was in favour of trying to improve palliation and perhaps obtain a longer survival time with chemotherapy. Unfortunately the disease was shown to be unresponsive to the chemotherapeutic regimen used, and the patient condition rapidly deteriorated, not allowing further treatments.
